arcus biosciences stock buy or sell

Is Arcus Biosciences Inc NYSERCUS stock a buy or a sell. Stock price up more than 578 on Friday Updated on Oct 21 2022 Buy or Hold candidate since 2022-10-17 Gain 215 PDF The Arcus Biosciences Inc.

Zwzc1b00svbk1m

Check out the forecast and prediction here.

. The financial health and. Find the latest Arcus Biosciences Inc. 72 US57m US797m Based on the trailing twelve months to March 2022.

Based on estimates by 12 analysts where scores have ranged from 100 for a strong buy to 500 for a strong sell 1 have rated the Arcus Biosciences Inc. Its Value Score of C indicates it would be a neutral pick for value investors. Arcus Biosciences is a biotech company located in California United States which is part of the Healthcare sector and is traded under the ticker RCUS on the NYSE exchange.

The average rating score is and is based on 12 buy ratings. RCUS stock quote history news and other vital information to help you with your stock trading and investing. So based on the above formula the ROE for Arcus Biosciences is.

Has a fifty-two week low of 1674 and a fifty-two week high. Arcus Biosciences Stock Up 14. Strong Buy 13 5 Buy Hold Sell Arcus Biosciences Stock.

Shares of RCUS stock opened at 2820 on Thursday. During the day the price has varied from a low of. Insider Buying and Selling at Arcus Biosciences In other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of the firms stock in a transaction dated Friday.

Arcus Biosciences is a biopharmaceutical company. The average price target is 4743 with a high forecast. Industry stock comparison between Arcus Biosciences and DaVita.

Arcus Biosciences Inc. The companys product portfolio includes AB928 AB122. The return is the amount.

May be fairly valued. Arcus Biosciences Stock Rating What analysts recommend for RCUS stock on a scale from 1 buy to 5 sell. However you should decide whether Arcus Biosciences Inc stock is a buy sell or hold based on a combination of grades metrics ratios and US.

On average Wall Street analysts predict that Arcus Biosciences s share price could reach 5450 by Oct 11 2023. Are you interested in Arcus Biosciences Inc. The stock was sold at an.

Valuation metrics show that Arcus Biosciences Inc. It opened the day at 2872 after a previous close of 2875. Based on 7 Wall Street analysts offering 12 month price targets for Arcus Biosciences in the last 3 months.

If yes then on this page you will find useful information about the dynamics of the RCUS stock price in 2022. The average Arcus Biosciences stock price prediction forecasts a potential. Macroaxis provides Arcus Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RCUS.

Arcus Biosciences RCUS is a leading biotechnology business based in the US. Arcus Biosciences stock has received a consensus rating of buy. RCUS Stock Price Prediction.

RCUS stock as a. It focused on creating innovative cancer immunotherapies. In other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of Arcus Biosciences stock in a transaction on Friday September 16th.

Is Arcus Biosciences stock a Buy Sell or Hold.

Arcus Biosciences Nyse Rcus Share Price News Analysis Simply Wall St